Profile
James C.
Lancaster Jr. has been Vice President of Commercial Operations for OREXIGEN Therapeutics, Inc. since August 2006.
Previously, he was a Marketing Consultant for Alkermes, Inc., G & S Research, Inc., Corcept Therapeutics, Inc., Neuronetics, Inc. and Eli Lilly and Company from March 2004 to August 2006.
Mr. Lancaster received a BS degree in Pharmacy from the University of Tennessee.
Former positions of James C. Lancaster
| Companies | Position | End |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 2008-03-09 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2003-01-31 |
Training of James C. Lancaster
| University of Tennessee | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- James C. Lancaster
